@[email protected] to [email protected]English • 11 months agoSemaglutide (Wegovy) reduces risk of serious cardiovascular events such as heart attacks by 20% in overweight patients with a history of cardiovascular disease and no history of diabeteswww.nejm.orgmessage-square3fedilinkarrow-up124arrow-down10
arrow-up124arrow-down1external-linkSemaglutide (Wegovy) reduces risk of serious cardiovascular events such as heart attacks by 20% in overweight patients with a history of cardiovascular disease and no history of diabeteswww.nejm.org@[email protected] to [email protected]English • 11 months agomessage-square3fedilink
minus-square😈MedicPig🐷BabySaver😈link1•11 months agoYeah, I haven’t heard any “good” stories. It’s definitely one of those treatments might be worse than the illness.
Yeah, I haven’t heard any “good” stories. It’s definitely one of those treatments might be worse than the illness.